Form D · Other Technology
American Pharma Technologies Inc.
Boise, ID · CIK 0001638942
Offering snapshot reported Apr 21, 2015 · SEC filing
- Reported sold
- $200K Offering amount: $450K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $75K Reported outside-investor minimum
- First sale
- Apr 9, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2015 | Initial | $200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-238325
Convertible Promissory Notes
Source: Form D, filed Apr 21, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Altree | Executive |
| Roy Glen | Director |
| Casey Harris | Director, Executive |
| Gene Loli | Executive |
| Ray Sasso | Director, Executive |
| Bryan Shannon | Executive |
| Mike Zeigler | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
280 N. 8 Th Street Suite 205
Boise, ID, 83702
Boise, ID, 83702